Fibroblasts constitute a significant proportion of the stromal compartment in many solid tumors and these infiltrating cells can acquire an activated cancer-associated fibroblast (CAF) phenotype. There is now extensive evidence functionally implicating CAFs in tumor progression via their ability to deposit and remodel extracellular matrix components, secrete pro-tumorigenic factors and modulate the immune compartment.
In breast cancer this so-called ‘desmoplastic response’ shows a clinical correlation with invasion and poor patient prognosis. In addition, there is an increasing body of data supporting a role of CAFs in promoting resistance to chemotherapy and targeted agents.
Despite the growing interest in the functional role of CAFs in tumors, much of their biology remains a mystery because of the lack of specific markers, as well as fibroblast phenotypic plasticity and heterogeneity both in vivo and in vitro.
Together, these have hampered efforts to disentangle the mechanisms underlying tumor:fibroblast crosstalk that could reveal novel strategies for disrupting stromal activation and thereby enhancing therapeutic targeting of tumor cells.
Using in vivo models researchers identify Wnt7a as a key factor secreted exclusively by aggressive breast tumor cells, which induces CAF conversion.
Functionally, this results in extracellular matrix remodelling to create a permissive environment for tumor cell invasion and promotion of distant metastasis.
Mechanistically, Wnt7a-mediated fibroblast activation is not dependent on classical Wnt signalling. Instead, authors demonstrate that Wnt7a potentiates TGFβ receptor signalling both in 3D in vitro and in vivo models, thus highlighting the interaction between two of the key signalling pathways in development and disease.
Importantly, in clinical breast cancer cohorts, tumor cell Wnt7a expression correlates with a desmoplastic, poor-prognosis stroma and poor patient outcome.
http://www.nature.com/ncomms/2016/160118/ncomms10305/full/ncomms10305.html
Tumor:fibroblast crosstalk mechanism to promote cancer aggressiveness
- 1,792 views
- Added
Edited
Latest News
Circadian rhythms can influ…
By newseditor
Posted 27 Apr
With hybrid brains, these m…
By newseditor
Posted 27 Apr
Blocking activation of NF-κ…
By newseditor
Posted 27 Apr
Vitamin D regulates microbi…
By newseditor
Posted 27 Apr
Role of alternative splicin…
By newseditor
Posted 27 Apr
Other Top Stories
Taste center of the human brain!
Read more
Inactive ingredients in pills and capsules may cause allergic, adve…
Read more
Two-drug combos using popular calcium channel blocker show superior…
In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel blocker, amlodipine, were able to drive down blood pressure levels more than a third two-drug combination that did not include amlodipine, according to research presented at the American College…
Read more
The brain pathway responsible for alcohol cravings
Read more
Diet sodas linked to increased risk of stroke in women over 50
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Single dose creatine improv…
By newseditor
Posted 27 Apr
Autonomous circadian rhythm…
By newseditor
Posted 27 Apr
Functional sensory circuits…
By newseditor
Posted 27 Apr
Positive selection CRISPR s…
By newseditor
Posted 27 Apr
Focal clusters of peri-syna…
By newseditor
Posted 27 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar